PL1658281T3 - Sposób usuwania trifenylometanowej grupy zabezpieczającej - Google Patents

Sposób usuwania trifenylometanowej grupy zabezpieczającej

Info

Publication number
PL1658281T3
PL1658281T3 PL04762303T PL04762303T PL1658281T3 PL 1658281 T3 PL1658281 T3 PL 1658281T3 PL 04762303 T PL04762303 T PL 04762303T PL 04762303 T PL04762303 T PL 04762303T PL 1658281 T3 PL1658281 T3 PL 1658281T3
Authority
PL
Poland
Prior art keywords
sup
protecting group
triphenylmethane protecting
triphenylmethane
ring
Prior art date
Application number
PL04762303T
Other languages
English (en)
Inventor
Stanislav Radl
Jan Stach
Ondrej Klecan
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20032319A external-priority patent/CZ297016B6/cs
Priority claimed from CZ20040733A external-priority patent/CZ298329B6/cs
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PL1658281T3 publication Critical patent/PL1658281T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Dicing (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Electron Tubes, Discharge Lamp Vessels, Lead-In Wires, And The Like (AREA)
PL04762303T 2003-08-27 2004-08-26 Sposób usuwania trifenylometanowej grupy zabezpieczającej PL1658281T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CZ20032319A CZ297016B6 (cs) 2003-08-27 2003-08-27 Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
CZ20040733A CZ298329B6 (cs) 2004-06-16 2004-06-16 Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2´-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
EP04762303A EP1658281B1 (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group
PCT/CZ2004/000051 WO2005021535A2 (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group

Publications (1)

Publication Number Publication Date
PL1658281T3 true PL1658281T3 (pl) 2010-12-31

Family

ID=34276338

Family Applications (2)

Application Number Title Priority Date Filing Date
PL379886A PL379886A1 (pl) 2003-08-27 2004-08-26 Sposób usuwania trifenylometanowej grupy zabezpieczającej
PL04762303T PL1658281T3 (pl) 2003-08-27 2004-08-26 Sposób usuwania trifenylometanowej grupy zabezpieczającej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL379886A PL379886A1 (pl) 2003-08-27 2004-08-26 Sposób usuwania trifenylometanowej grupy zabezpieczającej

Country Status (13)

Country Link
US (1) US20060287537A1 (pl)
EP (1) EP1658281B1 (pl)
AT (1) ATE482950T1 (pl)
CA (1) CA2536781A1 (pl)
DE (1) DE602004029373D1 (pl)
EA (1) EA011507B1 (pl)
ES (1) ES2348300T3 (pl)
HR (1) HRP20060119A2 (pl)
PL (2) PL379886A1 (pl)
PT (1) PT1658281E (pl)
RS (1) RS20060125A (pl)
SK (1) SK50142006A3 (pl)
WO (1) WO2005021535A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
EP1812423A1 (en) * 2004-11-11 2007-08-01 LEK Pharmaceuticals D.D. Process for the synthesis of tetrazoles
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299902B6 (cs) * 2005-10-27 2008-12-29 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
US8492577B2 (en) 2008-04-07 2013-07-23 Hetero Research Foundation Process for preparation of valsartan intermediate
WO2010046804A2 (en) * 2008-10-21 2010-04-29 Alembic Limited A process for preparation of losartan potassium form i
EP2432777A1 (en) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN103012382B (zh) * 2012-12-05 2016-10-05 迪沙药业集团有限公司 一种奥美沙坦酯的制备方法
US10323029B2 (en) 2014-09-29 2019-06-18 The Scripps Research Institute Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0443983T3 (da) * 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
AT395853B (de) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
SK722003A3 (en) * 2001-05-18 2003-12-02 Aurobindo Pharma Ltd Process for the crystallization of losartan potassium

Also Published As

Publication number Publication date
WO2005021535A2 (en) 2005-03-10
RS20060125A (en) 2008-06-05
EA011507B1 (ru) 2009-04-28
SK50142006A3 (sk) 2006-05-04
EP1658281B1 (en) 2010-09-29
DE602004029373D1 (de) 2010-11-11
ATE482950T1 (de) 2010-10-15
WO2005021535A3 (en) 2005-06-09
US20060287537A1 (en) 2006-12-21
PT1658281E (pt) 2010-10-12
HRP20060119A2 (en) 2006-05-31
EA200600079A1 (ru) 2006-08-25
CA2536781A1 (en) 2005-03-10
ES2348300T3 (es) 2010-12-02
PL379886A1 (pl) 2006-11-27
EP1658281A2 (en) 2006-05-24

Similar Documents

Publication Publication Date Title
PL379886A1 (pl) Sposób usuwania trifenylometanowej grupy zabezpieczającej
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
RS54047B1 (en) PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
RS53348B (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
CL2011001586A1 (es) Metodo que comprende una composicion que contiene sulfoximida de 6-haloalquilpiridin-3-il-alquilo n-sustituida; composicion comprendiendo una mezcla estereoisomera de dicha sulfoximida en una formulacion farmaceutica acuosa.
MX337714B (es) Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk).
RS51161B (sr) 5-supstituisani hinolin- ili izohinolin-derivati,postupak za njihovo dobijanje i njihova primena u suzbijanju zapaljenja
WO2009019005A8 (en) Tricyclic bridged cyclopentanedione derivatives as herbicides
WO2009156861A3 (en) Substituted pyrimidone derivatives
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
SV2010003483A (es) Pirimidinas biciclicas fusionadas
WO2008136444A1 (ja) 縮合複素環誘導体
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
RS54146B1 (en) CIKLOPENTILAKRILAMIDA DERIVATIVES
UA100376C2 (en) Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
EA201170595A1 (ru) ПРОИЗВОДНОЕ ФЕНАНТРОИНДОЛИЗИДИНА И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА
WO2004031160A3 (fr) Composes derives de la 2-thiohydantoïne et leur utilisation pour le traitement du diabete
MX2010001566A (es) Derivado de aminopirazolamida.
WO2007134149A3 (en) 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
EA201170596A1 (ru) ФЕНАНТРОИНДОЛИЗИДИНОВОЕ СОЕДИНЕНИЕ И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ ДЕЙСТВУЮЩЕГО ИНГРЕДИЕНТА
EA201070010A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
CO5680409A2 (es) Derivados de benzazepina como inhibidores de mao-b
PE20090822A1 (es) DERIVADO DE 17ß-CIANO-19-NOR-ANDROST-4-ENO, SU USO Y MEDICAMENTO QUE LO CONTIENE